| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.001 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |